⌘K

Login Start Free

Home/Filings/4/0001179110-17-001818

4//SEC Filing

RIGEL PHARMACEUTICALS INC 4

Accession 0001179110-17-001818

$RIGLCIK 0001034842operating

View on SEC.gov Company Profile

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 7:25 PM ET

Size

5.1 KB

Accession

0001179110-17-001818

Insider Transaction Report

Form 4

Period: 2017-02-02

RIGEL PHARMACEUTICALS INCRIGL

Duliege Anne-Marie

Chief Medical Officer

Transactions

Award
Stock Option (Right to Buy)
2017-02-02+150,000→ 150,000 total
Exercise: $2.11Exp: 2027-02-02→ Common Stock (150,000 underlying)

Footnotes (1)

[F1]The shares vest monthly over four (4) years from January 1, 2017.

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

RIGEL PHARMACEUTICALS INC

CIK 0001034842

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001034842

Filing Metadata

Form type: 4
Filed: Feb 5, 7:00 PM ET
Accepted: Feb 6, 7:25 PM ET
Size: 5.1 KB

View on SEC.gov